ClearPoint Neuro, Inc. (CLPT)
9.075
-0.30
(-3.25%)
USD |
NASDAQ |
Apr 07, 16:00
9.30
+0.22
(+2.48%)
After-Hours: 20:00
ClearPoint Neuro EPS Diluted (Quarterly) : -0.271 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Boston Scientific Corp. | 0.4493 |
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Plus Therapeutics, Inc. | -1.03 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.786M |
| Revenue (Quarterly) | 10.41M |
| Total Expenses (Quarterly) | 18.20M |
| Enterprise Value | 290.56M |
| Gross Profit Margin (Quarterly) | 61.52% |
| Profit Margin (Quarterly) | -74.79% |
| Earnings Yield | -9.94% |
| Normalized Earnings Yield | -9.942 |